Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

2,140 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Optimal dosage regimen of meropenem for pediatric patients based on pharmacokinetic/pharmacodynamic considerations.
Ohata Y, Tomita Y, Nakayama M, Kozuki T, Sunakawa K, Tanigawara Y. Ohata Y, et al. Among authors: tomita y. Drug Metab Pharmacokinet. 2011;26(5):523-31. doi: 10.2133/dmpk.dmpk-11-rg-027. Epub 2011 Jul 12. Drug Metab Pharmacokinet. 2011. PMID: 21747200 Clinical Trial.
Optimal treatment schedule of meropenem for adult patients with febrile neutropenia based on pharmacokinetic-pharmacodynamic analysis.
Ohata Y, Tomita Y, Nakayama M, Tamura K, Tanigawara Y. Ohata Y, et al. Among authors: tomita y. J Infect Chemother. 2011 Dec;17(6):831-41. doi: 10.1007/s10156-011-0271-9. Epub 2011 Jul 20. J Infect Chemother. 2011. PMID: 21773752 Clinical Trial.
Pharmacokinetic evaluation of liposomal amphotericin B (L-AMB) in patients with invasive fungal infection: Population approach in Japanese pediatrics.
Ohata Y, Tomita Y, Suzuki K, Maniwa T, Yano Y, Sunakawa K. Ohata Y, et al. Among authors: tomita y. Drug Metab Pharmacokinet. 2015 Dec;30(6):400-9. doi: 10.1016/j.dmpk.2015.08.003. Epub 2015 Aug 28. Drug Metab Pharmacokinet. 2015. PMID: 26645511
Cerebrospinal pharmacokinetic and pharmacodynamic analysis of efficacy of meropenem in paediatric patients with bacterial meningitis.
Ohata Y, Tomita Y, Sunakawa K, Drusano GL, Tanigawara Y. Ohata Y, et al. Among authors: tomita y. Int J Antimicrob Agents. 2019 Sep;54(3):292-300. doi: 10.1016/j.ijantimicag.2019.06.021. Epub 2019 Jul 3. Int J Antimicrob Agents. 2019. PMID: 31279154
Prediction methods of drug-drug interactions of non-oral CYP3A4 substrates based on clinical interaction data after oral administrations - Validation with midazolam, alfentanil, and verapamil after intravenous administration and prediction for blonanserin transdermal patch.
Tomita Y, Yahata M, Hashimoto M, Nishimuta H, Kawaguchi H, Matsushita H, Kitamura A, Nishibe H, Natsui K, Watanabe T. Tomita Y, et al. Drug Metab Pharmacokinet. 2020 Aug;35(4):345-353. doi: 10.1016/j.dmpk.2020.03.006. Epub 2020 Apr 27. Drug Metab Pharmacokinet. 2020. PMID: 32660818
Pharmacokinetics of beclomethasone dipropionate in an hydrofluoroalkane-134a propellant system in Japanese children with bronchial asthma.
Teramoto T, Fukao T, Tomita Y, Terauchi Y, Hosoi K, Matsui E, Aoki M, Kondo N, Mikawa H. Teramoto T, et al. Among authors: tomita y. Allergol Int. 2006 Sep;55(3):317-20. doi: 10.2332/allergolint.55.317. Allergol Int. 2006. PMID: 17075274
Effects of sitting posture and jaw clenching on neck and trunk muscle activities during typing.
Tomita Y, Suzuki Y, Tanaka Y, Hasegawa Y, Yoshihara Y, Okura K, Matsuka Y. Tomita Y, et al. J Oral Rehabil. 2021 Jan 25. doi: 10.1111/joor.13152. Online ahead of print. J Oral Rehabil. 2021. PMID: 33492675
Sex differences in vocalizations to familiar or unfamiliar females in mice.
Sasaki E, Tomita Y, Kanno K. Sasaki E, et al. Among authors: tomita y. R Soc Open Sci. 2020 Dec 23;7(12):201529. doi: 10.1098/rsos.201529. eCollection 2020 Dec. R Soc Open Sci. 2020. PMID: 33489288 Free PMC article.
Effect of jaw clenching on postural adjustments to a predictable external perturbation.
Tomita Y, Tanaka Y, Sako K, Ono Y, Tanaka M. Tomita Y, et al. J Electromyogr Kinesiol. 2021 Jan 17;57:102512. doi: 10.1016/j.jelekin.2020.102512. Online ahead of print. J Electromyogr Kinesiol. 2021. PMID: 33485257
The efficacy of Vitamin K, a member of Naphthoquinones in the treatment of cancer: a systematic review and meta-analysis.
Ganbat D, Jugder BE, Ganbat L, Tomoeda M, Dungubat E, Takahashi Y, Ichiro M, Shiomi T, Tomita Y. Ganbat D, et al. Among authors: tomita y. Curr Cancer Drug Targets. 2021 Jan 20. doi: 10.2174/1568009621999210120182834. Online ahead of print. Curr Cancer Drug Targets. 2021. PMID: 33475062
2,140 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page